Rankings
▼
Calendar
FOLD Q4 2023 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$115M
+30.6% YoY
Gross Profit
$104M
90.2% margin
Operating Income
-$4M
-3.2% margin
Net Income
-$34M
-29.4% margin
EPS (Diluted)
$-0.12
QoQ Revenue Growth
+11.2%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$778M
Total Liabilities
$618M
Stockholders' Equity
$160M
Cash & Equivalents
$247M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$115M
$88M
+30.6%
Gross Profit
$104M
$79M
+31.8%
Operating Income
-$4M
-$42M
+91.3%
Net Income
-$34M
-$56M
+39.4%
Geographic Segments
Non-US
$72M
62%
UNITED STATES
$43M
38%
← FY 2023
All Quarters
Q1 2024 →